Stock listing
Paxman Ab
Selected listing: A2DTAT · LS · EUR · DE
Paxman Ab (Lang & Schwarz: A2DTAT), Health Technology. Latest release Sep 28, 2026: Paxman : California Enacts Landmark Scalp Cooling Coverage Legislation.

- Ticker
- Lang & Schwarz: A2DTAT
- Asset type
- Stock
- Sector
- Health Technology
- Industry
- Medical Specialties
- Exchange
- Lang & Schwarz
- Currency
- EUR
About Paxman Ab
The company focuses on developing innovative solutions in its industry. Paxman Ab aims to enhance its market presence and deliver value to its stakeholders.
Latest news from Paxman Ab
Paxman : California Enacts Landmark Scalp Cooling Coverage Legislation
September 28, 2026
Paxman : Announces FDA Regulatory Progress for Limb Cryocompression System
August 10, 2026
Paxman : CMS Proposes Important Medicare Payment Policy Change for Mechanical Scalp Cooling
July 16, 2026
Paxman : Expands Global Regulatory Certifications for Cryocompression Device for Prevention of Chemotherapy-induced Peripheral Neuropathy (CIPN)
July 14, 2026
Press release from PAXMAN AB’s 2026 Annual General Meeting
May 22, 2026
Events
Research Paxman Ab
Alternate listings
PAX:OMXSTO
SE · SEK
Alternate listing for Paxman Ab; the primary context on this page is A2DTAT:LS.
B0F:FWB
DE · EUR
Alternate listing for Paxman Ab; the primary context on this page is A2DTAT:LS.
A2DTAT:LSX
DE · EUR
Alternate listing for Paxman Ab; the primary context on this page is A2DTAT:LS.
PXMBF:OTC
US · USD
Alternate listing for Paxman Ab; the primary context on this page is A2DTAT:LS.